Candriam Luxembourg S.C.A. »

Monopar Therapeutics shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2026-06-30 $13M 143k 92.50

More positions owned by Candriam Luxembourg S.C.A.

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Palo Alto Networks (PANW)
Lam Research Corp Com New (LRCX)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Kla Corp Com New (KLAC)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Monopar Therapeutics

Henderson Group
Jupiter Topco
RA Capital Management
BlackRock
Deerfield Management Company
Saturn V Capital Management
Siren
ADAR1 Capital Management
Polar Capital Holdings
Vanguard Capital Management
Adage Capital Partners GP
TCG Crossover Management
Wellington Management Company
OrbiMed Advisors
Candriam Luxembourg S.C.A.

View all funds holding Monopar Therapeutics